Form CORRESP - Correspondence:
SEC Accession No. 0001641172-25-005445
Filing Date
2025-04-18
Accepted
2025-04-18 17:04:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 12066
  Complete submission text file 0001641172-25-005445.txt   13189
Mailing Address 194 CANDELARO DRIVE, #233 HUMACAO PR 00791
Business Address 194 CANDELARO DRIVE, #233 HUMACAO PR 00791 561-704-8527
Aspire Biopharma Holdings, Inc. (Filer) CIK: 0001847345 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)